Indeed, the first results supporting the involvement of DNA methylation in the pathogenesis of AD were published in 1995, in a study reporting lower methylation levels of the APP promoter region in the temporal lobe of an AD patient compared to a non-demented subject [37]. This evidence concerns the gene APP and Alzheimer disease.